231 related articles for article (PubMed ID: 23253427)
1. Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs).
Motterlini R; Sawle P; Hammad J; Mann BE; Johnson TR; Green CJ; Foresti R
Pharmacol Res; 2013 Feb; 68(1):108-17. PubMed ID: 23253427
[TBL] [Abstract][Full Text] [Related]
2. Bioactive properties of iron-containing carbon monoxide-releasing molecules.
Sawle P; Hammad J; Fairlamb IJ; Moulton B; O'Brien CT; Lynam JM; Duhme-Klair AK; Foresti R; Motterlini R
J Pharmacol Exp Ther; 2006 Jul; 318(1):403-10. PubMed ID: 16603670
[TBL] [Abstract][Full Text] [Related]
3. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule.
Foresti R; Hammad J; Clark JE; Johnson TR; Mann BE; Friebe A; Green CJ; Motterlini R
Br J Pharmacol; 2004 Jun; 142(3):453-60. PubMed ID: 15148243
[TBL] [Abstract][Full Text] [Related]
5. Eta(1)-2-pyrone metal carbonyl complexes as CO-releasing molecules (CO-RMs): a delicate balance between stability and CO liberation.
Fairlamb IJ; Lynam JM; Moulton BE; Taylor IE; Duhme-Klair AK; Sawle P; Motterlini R
Dalton Trans; 2007 Sep; (33):3603-5. PubMed ID: 17700821
[TBL] [Abstract][Full Text] [Related]
6. Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.
Chatterjee PK
Br J Pharmacol; 2004 Jun; 142(3):391-3. PubMed ID: 15148242
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the vasorelaxing effects of CORM-3, a water-soluble carbon monoxide-releasing molecule: interactions with eNOS.
Alshehri A; Bourguignon MP; Clavreul N; Badier-Commander C; Gosgnach W; Simonet S; Vayssettes-Courchay C; Cordi A; Fabiani JN; Verbeuren TJ; Félétou M
Naunyn Schmiedebergs Arch Pharmacol; 2013 Mar; 386(3):185-96. PubMed ID: 23296254
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.
Sawle P; Foresti R; Mann BE; Johnson TR; Green CJ; Motterlini R
Br J Pharmacol; 2005 Jul; 145(6):800-10. PubMed ID: 15880142
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities.
Motterlini R; Clark JE; Foresti R; Sarathchandra P; Mann BE; Green CJ
Circ Res; 2002 Feb; 90(2):E17-24. PubMed ID: 11834719
[TBL] [Abstract][Full Text] [Related]
11. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
Desmard M; Foresti R; Morin D; Dagouassat M; Berdeaux A; Denamur E; Crook SH; Mann BE; Scapens D; Montravers P; Boczkowski J; Motterlini R
Antioxid Redox Signal; 2012 Jan; 16(2):153-63. PubMed ID: 21864022
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
13. Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart.
Musameh MD; Fuller BJ; Mann BE; Green CJ; Motterlini R
Br J Pharmacol; 2006 Dec; 149(8):1104-12. PubMed ID: 17057755
[TBL] [Abstract][Full Text] [Related]
14. Vascular and angiogenic activities of CORM-401, an oxidant-sensitive CO-releasing molecule.
Fayad-Kobeissi S; Ratovonantenaina J; Dabiré H; Wilson JL; Rodriguez AM; Berdeaux A; Dubois-Randé JL; Mann BE; Motterlini R; Foresti R
Biochem Pharmacol; 2016 Feb; 102():64-77. PubMed ID: 26721585
[TBL] [Abstract][Full Text] [Related]
15. Divergent mechanisms involved in CO and CORM-2 induced vasorelaxation.
Decaluwé K; Pauwels B; Verpoest S; Van de Voorde J
Eur J Pharmacol; 2012 Jan; 674(2-3):370-7. PubMed ID: 22108549
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice.
Cepinskas G; Katada K; Bihari A; Potter RF
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G184-91. PubMed ID: 17991708
[TBL] [Abstract][Full Text] [Related]
17. Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery.
Qureshi OS; Zeb A; Akram M; Kim MS; Kang JH; Kim HS; Majid A; Han I; Chang SY; Bae ON; Kim JK
Eur J Pharm Biopharm; 2016 Nov; 108():187-195. PubMed ID: 27634645
[TBL] [Abstract][Full Text] [Related]
18. Eta4-pyrone iron(0)carbonyl complexes as effective CO-releasing molecules (CO-RMs).
Fairlamb IJ; Duhme-Klair AK; Lynam JM; Moulton BE; O'Brien CT; Sawle P; Hammad J; Motterlini R
Bioorg Med Chem Lett; 2006 Feb; 16(4):995-8. PubMed ID: 16289810
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages.
Tsoyi K; Nizamutdinova IT; Jang HJ; Mun L; Kim HJ; Seo HG; Lee JH; Chang KC
Shock; 2010 Dec; 34(6):608-14. PubMed ID: 20442692
[TBL] [Abstract][Full Text] [Related]
20. Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs.
Pak O; Bakr AG; Gierhardt M; Albus J; Strielkov I; Kroschel F; Hoeres T; Hecker M; Ghofrani HA; Seeger W; Weissmann N; Sommer N
J Appl Physiol (1985); 2016 Jan; 120(2):271-81. PubMed ID: 26586910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
